{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:52:41Z","timestamp":1768564361441,"version":"3.49.0"},"posted":{"date-parts":[[2023,1,28]]},"group-title":"Addiction Medicine","reference-count":48,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Fentanyl- and methamphetamine-based counterfeit prescription drugs have driven escalating overdose death rates in the US, however their presence in Mexico has not been assessed. Our ethnographic team has conducted longitudinal research focused on illicit drug markets in Northern Mexico since 2018. In 2021-2022, study participants described the arrival of new, unusually potent tablets sold as ostensibly controlled substances, without a prescription, directly from pharmacies that cater to US tourists.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To characterize the availability of counterfeit and authentic controlled substances at pharmacies in Northern Mexico available to English-speaking tourists without a prescription.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We employed an iterative, exploratory, mixed methods design. Longitudinal ethnographic data was used to characterize tourist-oriented micro-neighborhoods and guide the selection of n=40 pharmacies in n=4 cities in Northern Mexico. In each pharmacy, samples of \u201coxycodone\u201d, \u201cXanax\u201d, and \u201cAdderall\u201d were sought as single pills, during English-language encounters, after which detailed ethnographic accounts were recorded. We employed immunoassay-based testing strips to check each pill for the presence of fentanyls, benzodiazepines, amphetamines, and methamphetamines. We used Fourier-Transform Infrared Spectroscopy to further characterize drug contents.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of n=40 pharmacies, one or more of the requested controlled substance could be obtained with no prescription (as single pills or in bottles) at 28 (70.0%) and as single pills at 19 (47.5%). Counterfeit pills were obtained at 11 pharmacies (27.5%). Of n=45 samples sold as one-off controlled substances, 18 were counterfeit. 7 of 11 (63.6%) samples sold as \u201cAdderall\u201d contained methamphetamine, 8 of 27 (29.6%) samples sold as \u201cOxycodone\u201d contained fentanyl, and 3 \u201cOxycodone\u201d samples contained heroin. Pharmacies providing counterfeit drugs were uniformly located in tourist-serving micro-neighborhoods, and generally featured English-language advertisements for erectile dysfunction medications and \u201cpainkillers\u201d. Pharmacy employees occasionally expressed concern about overdose risk and provided harm reduction guidance.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The availability of fentanyl-, heroin-, and methamphetamine-based counterfeit medications in tourist-oriented independent pharmacies in Northern Mexico represents a public health risk, and occurs in the context of 1) the normalization of medical tourism as a response to rising unaffordability of healthcare in the US, 2) plummeting rates of opioid prescription in the US, affecting both chronic pain patients and the availability of legitimate pharmaceuticals on the unregulated market, 3) the rise of fentanyl-based counterfeit opioids as a key driver of the fourth, and deadliest-to-date, wave of the opioid crisis. It was not possible to distinguish counterfeit medications based on appearance of pills or geography of pharmacies, because identically-appearing authentic and counterfeit versions were often sold in close geographic proximity. Nevertheless, drug consumers may be more trusting of controlled substances purchased directly from pharmacies. Due to Mexico\u2019s limited opioid overdose surveillance infrastructure, the current death rate from these substances remains unknown.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.01.27.23285123","type":"posted-content","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T20:00:13Z","timestamp":1674936013000},"source":"Crossref","is-referenced-by-count":5,"title":["Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study"],"prefix":"10.64898","author":[{"given":"Joseph","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Godvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Borquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tucker","family":"Avra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goodman-Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffanie","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bourgois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea L.","family":"Shover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023060212301581000_2023.01.27.23285123v2.1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.4310"},{"key":"2023060212301581000_2023.01.27.23285123v2.2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00634-4"},{"key":"2023060212301581000_2023.01.27.23285123v2.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2847"},{"key":"2023060212301581000_2023.01.27.23285123v2.4","unstructured":"CCENDU Drug Alert: Increasing Availability of Counterfeit Oxycodone Tablets Containing Fentanyl."},{"issue":"16","key":"2023060212301581000_2023.01.27.23285123v2.5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.15585\/mmwr.mm6516e1","article-title":"Counterfeit Norco Poisoning Outbreak \u2014 San Francisco Bay Area, California, March 25\u2013April 5, 2016","volume":"65","year":"2016","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"2023060212301581000_2023.01.27.23285123v2.6","unstructured":"Counterfeit Prescription Pills Containing Fentanyls: A Global Threat."},{"key":"2023060212301581000_2023.01.27.23285123v2.7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7050e3"},{"key":"2023060212301581000_2023.01.27.23285123v2.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108314"},{"key":"2023060212301581000_2023.01.27.23285123v2.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109398"},{"key":"2023060212301581000_2023.01.27.23285123v2.10","unstructured":"Monitoring the Future: Data for In-School Surveys of 8th, 10th, and 12th Grade Student, 1975-2021, Prevalence Trends by Drug. University of Michigan Accessed February 7, 2022. http:\/\/monitoringthefuture.org\/data\/21data.htm"},{"key":"2023060212301581000_2023.01.27.23285123v2.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103169"},{"key":"2023060212301581000_2023.01.27.23285123v2.12","doi-asserted-by":"publisher","DOI":"10.1111\/add.15734"},{"key":"2023060212301581000_2023.01.27.23285123v2.13","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13004"},{"key":"2023060212301581000_2023.01.27.23285123v2.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102661"},{"key":"2023060212301581000_2023.01.27.23285123v2.15","unstructured":"Millar A. Addressing the rise of counterfeit medicines in Africa. Pharmaceutical Technology. Published January 3, 2020. Accessed March 12, 2023. https:\/\/www.pharmaceutical-technology.com\/features\/counterfeit-drugs-africa\/"},{"key":"2023060212301581000_2023.01.27.23285123v2.16","doi-asserted-by":"publisher","DOI":"10.1093\/jiplp\/jpaa073"},{"key":"2023060212301581000_2023.01.27.23285123v2.17","unstructured":"A look inside Latin America\u2019s war on counterfeit medicines. The Pharma Letter. Published 2022. Accessed March 12, 2023. https:\/\/www.thepharmaletter.com\/article\/a-look-inside-latin-america-s-war-on-counterfeit-medicines"},{"key":"2023060212301581000_2023.01.27.23285123v2.18","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.125"},{"key":"2023060212301581000_2023.01.27.23285123v2.19","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306796"},{"key":"2023060212301581000_2023.01.27.23285123v2.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.115044"},{"key":"2023060212301581000_2023.01.27.23285123v2.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103678"},{"key":"2023060212301581000_2023.01.27.23285123v2.22","unstructured":"Montero Castrillo F , Friedman J , Bourgois P. Potency-Enhancing Synthetics in the Ongoing \u201cWaves\u201d of the Opioid Overdose Epidemic: Street User Perspectives on Xylazine, Fentanyl, Methamphetamine, and \u201cReal Heroin\u201d in Philadelphia and Tijuana. In Press."},{"key":"2023060212301581000_2023.01.27.23285123v2.23","unstructured":"DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl. Accessed January 25, 2023. https:\/\/www.dea.gov\/press-releases\/2021\/09\/27\/dea-washington-chief-issues-public-safety-alert-dangerous-increase-fake"},{"key":"2023060212301581000_2023.01.27.23285123v2.24","doi-asserted-by":"publisher","DOI":"10.31389\/jied.45"},{"key":"2023060212301581000_2023.01.27.23285123v2.25","doi-asserted-by":"publisher","DOI":"10.1111\/add.14934"},{"key":"2023060212301581000_2023.01.27.23285123v2.26","unstructured":"Gilmour S , Allum F. The Edward Elgar Handbook of Organised Crime and Politics.; 2019."},{"key":"2023060212301581000_2023.01.27.23285123v2.27","unstructured":"Not sold here: limited access to legally available syringes at pharmacies in Tijuana, Mexico | Harm Reduction Journal | Full Text. Accessed January 26, 2023. https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-8-13#Abs1"},{"key":"2023060212301581000_2023.01.27.23285123v2.28","doi-asserted-by":"crossref","unstructured":"Bourgois P. In Search of Respect: Selling Crack in El Barrio. Cambridge University Press; 2003.","DOI":"10.1017\/CBO9780511808562"},{"key":"2023060212301581000_2023.01.27.23285123v2.29","unstructured":"Bourgois P , Schonberg J. Righteous Dopefiend. University of California Press; 2009."},{"key":"2023060212301581000_2023.01.27.23285123v2.30","doi-asserted-by":"publisher","DOI":"10.3109\/10826089809056260"},{"key":"2023060212301581000_2023.01.27.23285123v2.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00478-4"},{"key":"2023060212301581000_2023.01.27.23285123v2.32","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2014.57"},{"key":"2023060212301581000_2023.01.27.23285123v2.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tourman.2012.05.009"},{"issue":"1","key":"2023060212301581000_2023.01.27.23285123v2.34","first-page":"45","article-title":"An Approach to Medical Tourism on Mexico\u2019s Northern Border","volume":"6","year":"2015","journal-title":"Eurasia Border Review"},{"key":"2023060212301581000_2023.01.27.23285123v2.35","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.2234866"},{"key":"2023060212301581000_2023.01.27.23285123v2.36","doi-asserted-by":"publisher","DOI":"10.1353\/lag.2007.0042"},{"key":"2023060212301581000_2023.01.27.23285123v2.37","unstructured":"Rosenthal E. An American Sickness: How Healthcare Became Big Business and How You Can Take It Back. 1 edition. Penguin Press; 2017."},{"key":"2023060212301581000_2023.01.27.23285123v2.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11237"},{"issue":"2","key":"2023060212301581000_2023.01.27.23285123v2.39","first-page":"9","article-title":"Mexican Pharmacies and Antibiotic Consumption at the US-Mexico Border","volume":"5","year":"2012","journal-title":"South Med Rev"},{"key":"2023060212301581000_2023.01.27.23285123v2.40","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304767"},{"key":"2023060212301581000_2023.01.27.23285123v2.41","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30260-7"},{"key":"2023060212301581000_2023.01.27.23285123v2.42","unstructured":"U.S. Opioid Dispensing Rate Maps | Drug Overdose | CDC Injury Center. Published October 19, 2022. Accessed January 17, 2023. https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html"},{"key":"2023060212301581000_2023.01.27.23285123v2.43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00476"},{"key":"2023060212301581000_2023.01.27.23285123v2.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11013"},{"key":"2023060212301581000_2023.01.27.23285123v2.45","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002298"},{"key":"2023060212301581000_2023.01.27.23285123v2.46","unstructured":"Knibbs K. America\u2019s Adderall Shortage Could Kill People. Wired. Accessed January 17, 2023. https:\/\/www.wired.com\/story\/adderall-shortage-problems\/"},{"key":"2023060212301581000_2023.01.27.23285123v2.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.009"},{"key":"2023060212301581000_2023.01.27.23285123v2.48","doi-asserted-by":"publisher","DOI":"10.1080\/15389588.2011.631065"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.01.27.23285123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:26:06Z","timestamp":1768505166000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.01.27.23285123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1101\/2023.01.27.23285123","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.drugalcdep.2023.110819","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,1,28]]},"subtype":"preprint"}}